Middle East & Africa Infectious Disease Molecular Diagnostics Market Size & Outlook
Middle East & Africa infectious disease molecular diagnostics market, 2018-2030 (US$M)
Related Markets
MEA infectious disease molecular diagnostics market highlights
- The MEA infectious disease molecular diagnostics market generated a revenue of USD 541.8 million in 2024.
- The market is expected to grow at a CAGR of 5.2% from 2025 to 2030.
- In terms of segment, reagents product was the largest revenue generating product in 2024.
- Others Product is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 541.8 million |
| Market revenue in 2030 | USD 735.9 million |
| Growth rate | 5.2% (CAGR from 2025 to 2030) |
| Largest segment | Reagents product |
| Fastest growing segment | Others Product |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments Product, Reagents Product, Others Product |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.4% of the global infectious disease molecular diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Latin America is the fastest growing regional market and is projected to reach USD 1,034.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.63% in 2024. Horizon Databook has segmented the Middle East & Africa infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & African (MEA) countries such as South Africa, Saudi Arabia, and the UAE are prospering economies. The market in this region is driven by high prevalence of infectious diseases, rise in consumer awareness, and improvements in healthcare infrastructure.
Thus, MEA is mostly an untapped market for infectious diseases molecular diagnostics. Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are some of the primary growth drivers for this market.
There is high prevalence of communicable & infectious diseases in this region. However, ethical reasons, poor infrastructure, and affordability might hamper growth. Growing healthcare awareness, increasing initiatives undertaken by various NGOs, improved penetration of health insurance policies, and privatization are some of the factors anticipated to fuel regional market growth.
Reasons to subscribe to Middle East & Africa infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa infectious disease molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA infectious disease molecular diagnostics market size, by country, 2018-2030 (US$M)
Middle East & Africa Infectious Disease Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
